SCHEMBL20347010

SCHEMBL20347010

NCc1ccc(N2CCC3(CC2)OCCCO3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGMN Q99538 1/20 0.48
L3MBTL3 Q96JM7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RORC P51449 1/20 0.36
F12 P00748 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
TMPRSS6 Q8IU80 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
ST14 Q9Y5Y6 1/20 0.36
NCF1 P14598 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680323 0.94 LGMN (0.54) LGMNL3MBTL3L3MBTL1F12HRH3
SCHEMBL7365166 0.79 CHKA (0.50) L3MBTL1HRH3GRIN2DGRIN3BF2
SCHEMBL20345560 0.79 L3MBTL3 (0.34) L3MBTL3L3MBTL1NCF1CHKACA2
SCHEMBL6074426 0.78 LGMN (0.50) LGMNL3MBTL3L3MBTL1F12HRH3
SCHEMBL39888 0.76 LMNA (0.52) LGMNL3MBTL1NCF1KDM4ETSHR
SCHEMBL6674588 0.76 USP2 (0.41) L3MBTL1CHKAKDM4ETSHR
SCHEMBL112580 0.75 ALDH1A1 (0.54) L3MBTL1CHKAPRMT6KDM4EAGXT
SCHEMBL12294725 0.75 HRH3 (0.48) HRH3F2PRSS1PRSS2PRSS3
SCHEMBL20347012 0.75 KDM4E (0.50) LGMNPIK3CAMTORKDM4ETSHR
SCHEMBL6678586 0.75 GAA (0.37) HRH3F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230014173-A1 Antibacterial Compounds JANSSEN SCIENCES IRELAND UC (IE) 2023-01-19 US disclosed
US-11180472-B2 Antibacterial compounds JANSSEN SCIENCES IRELAND UC (IE) 2021-11-23 US disclosed
US-20200239434-A1 ANTIBACTERIAL COMPOUNDS JANSSEN SCIENCES IRELAND UC (IE) 2020-07-30 US disclosed
US-20190330189-A1 ANTIBACTERIAL COMPOUNDS JANSSEN SCIENCES IRELAND UC (IE) 2019-10-31 US disclosed
US-10364232-B2 Antibacterial compounds JANSSEN SCIENCES IRELAND UC (IE) 2019-07-30 US disclosed
US-20180186768-A1 Antibacterial Compounds JANSSEN SCIENCES IRELAND UC (IE) 2018-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11180472-B2 Antibacterial compounds FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885
US-20190330189-A1 ANTIBACTERIAL COMPOUNDS FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885
US-10364232-B2 Antibacterial compounds FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885
US-20180186768-A1 Antibacterial Compounds FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885
US-20230014173-A1 Antibacterial Compounds FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885
US-20200239434-A1 ANTIBACTERIAL COMPOUNDS FDPS, SQOR, NDUFS3 LGMN 699/4885L3MBTL3 1216/4885L3MBTL1 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.